Content about Chal

February 17, 2012
Retailers go local for homegrown product mix

Outside of TV land and around the country, going local isn’t just a punch line for an evening comedy show or even a peculiarity of the weekend farmers market. It’s an increasingly popular merchandising strategy for retail chains.


December 16, 2011
ERSP challenges stem cell claims made by online marketer Emergent Health

The Electronic Retailing Self-Regulation Program on Wednesday recommended that Emergent Health modify or discontinue certain Internet advertising claims for the company’s “JDI MultiVitamin,” promoted by the advertiser as designed to “increase adult stem cells.”

October 3, 2011
NAD challenges several Similac Advance claims

The National Advertising Division of the Council of Better Business Bureaus last week determined Abbott Nutrition could support certain advertising claims made for Similac Advance and Similac Sensitive infant formula. However, NAD recommended that Abbott modify or discontinue certain other claims.

April 25, 2011
Are coupon ‘extremists’ bad for business?

Call it “the attack of the coupon-crazed shelf sweepers.” It’s the most aggressive form of bargain hunting by consumers willing to spend hours searching out coupon deals, to stock up with enough product to last their families for a year and to turn their homes into veritable warehouses.


March 15, 2011
NAD refers Patent Health claims to FTC

The National Advertising Division of the Council of Better Business Bureaus on Monday referred advertising for the dietary supplement Trigosamine Fast Acting (Trigo FA) to the Federal Trade Commission for further review following Patent Health’s failure to modify claims.

December 22, 2010
Prilosec OTC’s ‘Heartburn gone … power on’ tagline nixed by NAD

The National Advertising Division of the Council of Better Business Bureaus on Tuesday ruled that Procter & Gamble provided reasonable support for claims that Prilosec OTC provides “superior acid control” over a competing product, Prevacid 24HR. However, the NAD recommended P&G discontinue a comparative claim made in a context that doesn’t reference acid control, the review board added.

© 2013 Drug Store News. All Rights Reserved.